You have 9 free searches left this month | for more free features.

multi-center randomized controlled trial.

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cataract Trial in Austria, Germany, Netherlands (remote monitoring after cataract surgery)

Recruiting
  • Cataract
  • remote monitoring after cataract surgery
  • Vienna, Austria
  • +5 more
Aug 16, 2022

Gastroenteritis Trial in Japan (Placebo, HIL-214)

Recruiting
  • Gastroenteritis
  • Placebo
  • HIL-214
  • Fukui-Shi, Japan
  • +3 more
Aug 18, 2023

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Primary Hypercholesterolemia Trial in Seoul (D377, CKD-331, D086)

Recruiting
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 12, 2022

Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)

Completed
  • Hypercholesterolemia, Dyslipidemia
  • Ezetimibe/Atorvastatin 10/5 mg
  • +7 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 24, 2023

Rheumatoid Arthritis Trial in Ann Arbor, Rochester, Columbus (Mobile Health App)

Recruiting
  • Rheumatoid Arthritis
  • Mobile Health App
  • Ann Arbor, Michigan
  • +1 more
Jan 4, 2023

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Homonymous Hemianopia Trial in Boston (Multi-Periscopic Prism (MPP) glasses, Fresnel Peripheral Prism (FPP) glasses)

Recruiting
  • Homonymous Hemianopia
  • Multi-Periscopic Prism (MPP) glasses
  • Fresnel Peripheral Prism (FPP) glasses
  • Birmingham, Alabama
  • +6 more
Jan 19, 2023

Nasopharyngeal Carcinoma, Radiotherapy; Complications Trial (Intensity Modulated Radiation Therapy, Chemotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Radiotherapy; Complications
  • (no location specified)
Mar 20, 2023

Cancer, Quality of Life, Anxiety Trial in United States (Promoting Resilience in Stress Management (PRISM))

Recruiting
  • Cancer
  • +6 more
  • Promoting Resilience in Stress Management (PRISM)
  • Los Angeles, California
  • +4 more
Nov 29, 2022

Transplant Complication Trial (Pooled allogeneic fecal microbiotherapy, Placebo)

Not yet recruiting
  • Transplant Complication
  • Pooled allogeneic fecal microbiotherapy
  • Placebo
  • (no location specified)
Feb 27, 2023

Drug-Induced Acute Liver Injury Trial in Shanghai (bicyclol, 25mg/ tablet, polyene phosphatidylcholine capsules, 228mg/

Recruiting
  • Drug-Induced Acute Liver Injury
  • bicyclol, 25mg/ tablet
  • polyene phosphatidylcholine capsules, 228mg/ particle.
  • Shanghai, Shanghai, China
  • +1 more
Aug 3, 2022

Advanced Solid Tumors Harboring NTRK Fusion, Primary CNS Tumors Harboring NTRK Fusion Trial in Guangzhou (ICP-723)

Recruiting
  • Advanced Solid Tumors Harboring NTRK Fusion
  • Primary Central Nervous System Tumors Harboring NTRK Fusion
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Feb 16, 2023

End Stage Renal Disease Trial in Shanghai (regular hemodialysis, hemoperfusion combined with hemodialysis)

Recruiting
  • End Stage Renal Disease
  • regular hemodialysis
  • hemoperfusion combined with hemodialysis
  • Shanghai, Shanghai, China
    Changhai Hospital
Feb 1, 2023

Diabetes, Type 2, Obesity Trial (endomina®)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Obesity
  • endomina®
  • (no location specified)
Aug 23, 2022

Post Traumatic Stress Disorder Trial (Intervention C Daridorexant, Intervention C Placebo)

Not yet recruiting
  • Post Traumatic Stress Disorder
  • Intervention C Daridorexant
  • Intervention C Placebo
  • (no location specified)
Jul 5, 2023

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Bowel Preparation Trial in Seoul (CTP0301-A, CTP0301-B, Cool prep)

Recruiting
  • Bowel Preparation
  • Seoul, Korea, Republic of
    Taejoon Pharmaceutical Co., Ltd.
May 21, 2023

Lymphedema Trial in Cairo (Multi-waved Locked System Laser, Cold Compression therapy, complete decongestive therapy)

Completed
  • Lymphedema
  • Multi-waved Locked System Laser
  • +2 more
  • Cairo, Egypt
    Kasr El-Einy Center of Radiation Oncology and Nuclear Medicine,
Jun 16, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Post Traumatic Stress Disorder Trial (Intervention B Vilazodone Hydrochloride, Intervention B Placebo)

Not yet recruiting
  • Post Traumatic Stress Disorder
  • Intervention B Vilazodone Hydrochloride
  • Intervention B Placebo
  • (no location specified)
Jul 5, 2023

Post Traumatic Stress Disorder Trial (Intervention A Fluoxetine HCl, Intervention A Placebo)

Not yet recruiting
  • Post Traumatic Stress Disorder
  • Intervention A Fluoxetine HCl
  • Intervention A Placebo
  • (no location specified)
Jul 5, 2023

Stone, Kidney Trial in Mansoura (Group A (p-PCNL) procedure, Group B (s-ECIRS) procedure)

Recruiting
  • Stone, Kidney
  • Group A (p-PCNL) procedure
  • Group B (s-ECIRS) procedure
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura Urology and Nephrology Center
Jul 13, 2022

Atrial Fibrillation, HFpEF - Heart Failure With Preserved Ejection Fraction Trial (Radiofrequency catheter ablation (RFCA),

Not yet recruiting
  • Atrial Fibrillation
  • HFpEF - Heart Failure With Preserved Ejection Fraction
  • Radiofrequency catheter ablation (RFCA)
  • Medical Therapy
  • (no location specified)
Nov 5, 2023